ENCLEAR THERAPIES

Developing the leading CSF Health Platform to improve and extend the lives of patients with CNS diseases.

NEURO SPECIALTY PHARMA

We are building an integrated neuro specialty pharma business using our CSF Health Platform to create a pipeline of significant near-term commercial opportunities. Launching into neuro-oncology, while leveraging business development to expand our portfolio into neurodegenerative, lysosomal storage & autoimmune diseases.

ABOUT ENCLEAR

Our mission is to extend the lives of patients with CNS-related disease.

​

Our opportunity is to utilize CSF for controlled, continuous, & personalized delivery to areas of the CNS most benefited by both existing & next-generation therapeutics.

​

Our strategy is two-fold:

1) Lead with neuro-oncology and help patients with Leptomeningeal Carcinomatosis.

2) Leveraging partnerships to expand into neurodegenerative, lysosomal storage & autoimmune diseases.

CSF HEALTH PLATFORM

Building a novel platform for localized CNS delivery of therapeutics & monitoring of CSF to ensure effective & personalized therapy.